164 related articles for article (PubMed ID: 12950150)
21. In situ expression of interleukin-4 (IL-4) receptors in human brain tumors and cytotoxicity of a recombinant IL-4 cytotoxin in primary glioblastoma cell cultures.
Joshi BH; Leland P; Asher A; Prayson RA; Varricchio F; Puri RK
Cancer Res; 2001 Nov; 61(22):8058-61. PubMed ID: 11719427
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.
Husain SR; Puri RK
J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884
[TBL] [Abstract][Full Text] [Related]
23. STAT-1 is activated by IL-4 and IL-13 in multiple cell types.
Wang IM; Lin H; Goldman SJ; Kobayashi M
Mol Immunol; 2004 Jul; 41(9):873-84. PubMed ID: 15261459
[TBL] [Abstract][Full Text] [Related]
24. Analysis of target genes induced by IL-13 cytotoxin in human glioblastoma cells.
Han J; Yang L; Puri RK
J Neurooncol; 2005 Mar; 72(1):35-46. PubMed ID: 15803373
[TBL] [Abstract][Full Text] [Related]
25. Potent antitumor activity of IL-13 cytotoxin in human pancreatic tumors engineered to express IL-13 receptor alpha2 chain in vivo.
Kawakami K; Kawakami M; Husain SR; Puri RK
Gene Ther; 2003 Jul; 10(13):1116-28. PubMed ID: 12808442
[TBL] [Abstract][Full Text] [Related]
26. Kinetic analysis of high affinity forms of interleukin (IL)-13 receptors: suppression of IL-13 binding by IL-2 receptor gamma chain.
Kuznetsov VA; Puri RK
Biophys J; 1999 Jul; 77(1):154-72. PubMed ID: 10388747
[TBL] [Abstract][Full Text] [Related]
27. [Growth promoting effect of IL-6 on medulloblastoma cells in vitro].
Liu J; Li H; Hamou MF
Zhonghua Zhong Liu Za Zhi; 1995 Jul; 17(4):271-4. PubMed ID: 7587893
[TBL] [Abstract][Full Text] [Related]
28. Expression of interleukin-13 receptor alpha 1-subunit on peripheral blood eosinophils is regulated by cytokines.
Myrtek D; Knoll M; Matthiesen T; Krause S; Lohrmann J; Schillinger D; Idzko M; Virchow JC; Friedrich K; Luttmann W
Immunology; 2004 Aug; 112(4):597-604. PubMed ID: 15270731
[TBL] [Abstract][Full Text] [Related]
29. Targeting of interleukin-13 receptor on human renal cell carcinoma cells by a recombinant chimeric protein composed of interleukin-13 and a truncated form of Pseudomonas exotoxin A (PE38QQR).
Puri RK; Leland P; Obiri NI; Husain SR; Kreitman RJ; Haas GP; Pastan I; Debinski W
Blood; 1996 May; 87(10):4333-9. PubMed ID: 8639793
[TBL] [Abstract][Full Text] [Related]
30. Interleukin 4 receptor-directed cytotoxin therapy for human head and neck squamous cell carcinoma in animal models.
Strome SE; Kawakami K; Alejandro D; Voss S; Kasperbauer JL; Salomao D; Chen L; Maki RA; Puri RK
Clin Cancer Res; 2002 Jan; 8(1):281-6. PubMed ID: 11801570
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-8/CXCL8 is a growth factor for human lung cancer cells.
Zhu YM; Webster SJ; Flower D; Woll PJ
Br J Cancer; 2004 Nov; 91(11):1970-6. PubMed ID: 15545974
[TBL] [Abstract][Full Text] [Related]
32. Characterization of interleukin-13 receptor in carcinoma cell lines and human blood cells and comparison with the interleukin-4 receptor.
Feng N; Schnyder B; Vonderschmitt DJ; Ryffel B; Lutz RA
J Recept Signal Transduct Res; 1995; 15(7-8):931-49. PubMed ID: 8673724
[TBL] [Abstract][Full Text] [Related]
33. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
[TBL] [Abstract][Full Text] [Related]
34. Expression of interleukin-9 in nasal natural killer/T-cell lymphoma cell lines and patients.
Nagato T; Kobayashi H; Kishibe K; Takahara M; Ogino T; Ishii H; Oikawa K; Aoki N; Sato K; Kimura S; Shimizu N; Tateno M; Harabuchi Y
Clin Cancer Res; 2005 Dec; 11(23):8250-7. PubMed ID: 16322282
[TBL] [Abstract][Full Text] [Related]
35. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
Kawakami K; Husain SR; Bright RK; Puri RK
Cancer Gene Ther; 2001 Nov; 8(11):861-8. PubMed ID: 11773976
[TBL] [Abstract][Full Text] [Related]
36. A recombinant IL-4-Pseudomonas exotoxin inhibits protein synthesis and overcomes apoptosis resistance in human CLL B cells.
Kay NE; Bone ND; Lee YK; Jelinek DF; Leland P; Battle TE; Frank DA; Puri RK
Leuk Res; 2005 Sep; 29(9):1009-18. PubMed ID: 16038727
[TBL] [Abstract][Full Text] [Related]
37. Molecular targeting with recombinant cytotoxins of interleukin-13 receptor alpha2-expressing glioma.
Mintz A; Gibo DM; Madhankumar AB; Debinski W
J Neurooncol; 2003; 64(1-2):117-23. PubMed ID: 12952292
[TBL] [Abstract][Full Text] [Related]
38. Interleukin 1 system and sex steroid receptor expression in human breast cancer: interleukin 1alpha protein secretion is correlated with malignant phenotype.
Singer CF; Kronsteiner N; Hudelist G; Marton E; Walter I; Kubista M; Czerwenka K; Schreiber M; Seifert M; Kubista E
Clin Cancer Res; 2003 Oct; 9(13):4877-83. PubMed ID: 14581361
[TBL] [Abstract][Full Text] [Related]
39. Role of interleukin-13 in cancer, pulmonary fibrosis, and other T(H)2-type diseases.
Joshi BH; Hogaboam C; Dover P; Husain SR; Puri RK
Vitam Horm; 2006; 74():479-504. PubMed ID: 17027527
[TBL] [Abstract][Full Text] [Related]
40. Functional VEGF and VEGF receptors are expressed in human medulloblastomas.
Slongo ML; Molena B; Brunati AM; Frasson M; Gardiman M; Carli M; Perilongo G; Rosolen A; Onisto M
Neuro Oncol; 2007 Oct; 9(4):384-92. PubMed ID: 17704359
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
